483 related articles for article (PubMed ID: 25855730)
1. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
Gromowski GD; Firestone CY; Whitehead SS
J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
[TBL] [Abstract][Full Text] [Related]
2. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
Yang D; Li XF; Ye Q; Wang HJ; Deng YQ; Zhu SY; Zhang Y; Li SH; Qin CF
Vaccine; 2014 May; 32(23):2675-81. PubMed ID: 24709585
[TBL] [Abstract][Full Text] [Related]
3. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.
Yun SI; Song BH; Kim JK; Yun GN; Lee EY; Li L; Kuhn RJ; Rossmann MG; Morrey JD; Lee YM
PLoS Pathog; 2014 Jul; 10(7):e1004290. PubMed ID: 25077483
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo.
Yun SI; Song BH; Polejaeva IA; Davies CJ; White KL; Lee YM
J Gen Virol; 2016 Oct; 97(10):2575-2591. PubMed ID: 27498826
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
Yu Y
Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
[TBL] [Abstract][Full Text] [Related]
7. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
Yang J; Yang H; Li Z; Wang W; Lin H; Liu L; Ni Q; Liu X; Zeng X; Wu Y; Li Y
Viruses; 2017 Jan; 9(1):. PubMed ID: 28117725
[TBL] [Abstract][Full Text] [Related]
8. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P
Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
[TBL] [Abstract][Full Text] [Related]
9. Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
Liu X; Zhao D; Jia L; Xu H; Na R; Ge Y; Liu S; Yu Y; Li Y
Vaccine; 2018 Jul; 36(31):4650-4656. PubMed ID: 29954631
[TBL] [Abstract][Full Text] [Related]
10. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2].
Zeng M; Jia LL; Yu YX; Dong GM; Liu WX; Wang ZW; Li DF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):9-11. PubMed ID: 16201461
[TBL] [Abstract][Full Text] [Related]
11. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
Yang H; Fan F; Liu L; Liu J; Sun Y; Xie A; Shi X; Liu L; Yu Y; Li Y; Ge Y; Zeng X; Yang H
Vaccine; 2020 Mar; 38(11):2636-2642. PubMed ID: 32044162
[TBL] [Abstract][Full Text] [Related]
12. Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine.
Ye Q; Xu YP; Zhang Y; Li XF; Wang HJ; Liu ZY; Li SH; Liu L; Zhao H; Nian QG; Deng YQ; Qin ED; Qin CF
J Gen Virol; 2015 Aug; 96(8):2165-2175. PubMed ID: 25908779
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.
Ni H; Chang GJ; Xie H; Trent DW; Barrett AD
J Gen Virol; 1995 Feb; 76 ( Pt 2)():409-13. PubMed ID: 7844560
[TBL] [Abstract][Full Text] [Related]
14. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity.
Xu G; Xu X; Li Z; He Q; Wu B; Sun S; Chen H
Vaccine; 2004 May; 22(15-16):1846-53. PubMed ID: 15121294
[TBL] [Abstract][Full Text] [Related]
15. Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.
Li Z; Yang H; Yang J; Lin H; Wang W; Liu L; Zhao Y; Liu L; Zeng X; Yu Y; Li Y
Virus Res; 2014 Oct; 191():10-20. PubMed ID: 25091563
[TBL] [Abstract][Full Text] [Related]
16. Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.
Gromowski GD; Firestone CY; Bustos-Arriaga J; Whitehead SS
Am J Trop Med Hyg; 2015 Jan; 92(1):98-107. PubMed ID: 25311701
[TBL] [Abstract][Full Text] [Related]
17. A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1' formation and contributes to attenuation.
Ye Q; Li XF; Zhao H; Li SH; Deng YQ; Cao RY; Song KY; Wang HJ; Hua RH; Yu YX; Zhou X; Qin ED; Qin CF
J Gen Virol; 2012 Sep; 93(Pt 9):1959-1964. PubMed ID: 22739060
[TBL] [Abstract][Full Text] [Related]
18. The pre membrane and envelope protein is the crucial virulence determinant of Japanese encephalitis virus.
Leng SL; Huang R; Feng YN; Peng LJ; Yang J; Li YH
Microb Pathog; 2020 Nov; 148():104492. PubMed ID: 32916243
[TBL] [Abstract][Full Text] [Related]
19. Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.
Song BH; Yun GN; Kim JK; Yun SI; Lee YM
J Microbiol; 2012 Aug; 50(4):698-706. PubMed ID: 22923123
[TBL] [Abstract][Full Text] [Related]
20. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
Sarkar A; Banik A; Pathak BK; Mukhopadhyay SK; Chatterjee S
BMC Infect Dis; 2013 Aug; 13():368. PubMed ID: 23927571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
